The insider selling is modest relative to market cap and consistent with post-exercise profit-taking. Monitor for any upcoming clinical data readouts or earnings that could provide context; no immediate trading action warranted.
Price Chart
Executive Summary
Three top executives at Maze Therapeutics (CEO, President R&D, CSBO) sold a combined ~$1.46M in shares over a three-day period, primarily following option exercises. The selling represents ~0.1% of market cap and appears routine, likely related to tax withholding or diversification. No material negative signal.
Key Financial Metrics
Key Facts
- CEO Jason Coloma sold ~$594K, President R&D Harold Bernstein sold ~$696K, CSBO Atul Dandekar sold ~$169K in open-market transactions
- Total open-market sales of ~$1.46M represent ~0.1% of MAZE's $1.4B market cap
- Sales coincided with option exercises (non-cash) on September 1, 2026, suggesting routine post-exercise profit-taking
- Four insiders (including GC Courtney Phillips) exercised derivatives with no associated sale, further indicating tax-planning activity
Financial Impact
Insider selling of approximately $1.46M, representing ~0.1% of market cap
Risk Factors
- Insider selling could precede negative news, but the small size limits signaling value
- Option exercises increase share count slightly, though dilution is minimal
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MAZE-1788555660017 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 27d ago | Insider Cluster | $26.37 $24.23 | ▼ −8.12% | ▼ −7.00% | $26.69 (+1.20%) |
Sep 4, 2026 27d ago | Insider Cluster | $26.37 $24.23 | ▼ −8.12% | ▼ −7.00% | $26.69 (+1.20%) |
Sep 3, 2026 29d ago | Insider Cluster | $25.87 $24.60 | ▼ −4.91% | ▼ −3.76% | $26.69 (+3.16%) |
Sep 2, 2026 29d ago | 144 | $25.87 $24.60 | ▼ −4.91% | ▼ −3.76% | $26.69 (+3.16%) |
Sep 1, 2026 4w ago | 144 | $26.72 $24.82 | ▼ −7.11% | ▼ −6.15% | $26.69 (−0.12%) |
Aug 17, 2026 6w ago | 3 | $29.13 $30.42 | ▲ +4.43% | ▲ +4.63% | $26.69 (−8.38%) |
Aug 11, 2026 7w ago | Press Release | $27.53 $29.75 | ▲ +8.06% | ▲ +8.51% | $26.69 (−3.06%) |
Aug 7, 2026 8w ago | Institutional Cluster | $28.65 $27.18 | ▼ −5.13% | ▼ −5.53% | $26.69 (−6.85%) |
Aug 5, 2026 8w ago | Insider Cluster | $27.81 $27.53 | ▼ −1.01% | ▼ −1.36% | $26.69 (−4.04%) |
Jul 2, 2026 13w ago | Insider Cluster | $31.26 $32.42 | ▲ +3.71% | ▲ +2.78% | $26.69 (−14.63%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access